The Questions Men Ask Before Starting TRT

Question 1

Do I really have low T—or is something else going on?

That is usually the first question, even when a man does not say it that way.

Fatigue, low libido, reduced strength, changes in body composition, irritability, and difficulty concentrating can occur with low testosterone. They can also occur with sleep apnea, thyroid disease, depression, anemia, medication effects, inadequate sleep, obesity, and other medical conditions.

I do not diagnose low testosterone from a symptom list or online quiz. Diagnosis requires compatible symptoms and consistently low testosterone measured with reliable morning testing, generally confirmed on a separate day, interpreted with the medical history and other laboratory results.

Some men who arrive expecting testosterone leave with a different explanation. That can still be a successful visit.

See how NovaGenix evaluates and tests for low testosterone →

Question 2

What testosterone number is actually “low”?

The American Urological Association identifies a total testosterone level below 300 ng/dL as a reasonable cutoff supporting the diagnosis of testosterone deficiency. That number is not a diagnosis by itself.

Testing should be performed in the morning and repeated. Laboratory methods and reference ranges vary. Free testosterone and sex hormone-binding globulin may add useful context in selected men, especially when total testosterone and symptoms do not align.

I do not treat a printout in isolation. I consider symptoms, repeat results, testing conditions, medications, health history, and possible causes together.

Question 3

Should I get tested just because I turned 40?

Not automatically. Testosterone may decline gradually with age, but age alone does not establish hypogonadism or create an indication for treatment.

Testing is more appropriate when compatible symptoms are present or when the history raises concern—for example, pituitary or testicular disease, certain medications, significant obesity or metabolic disease, prior chemotherapy or radiation, or previous anabolic-steroid exposure.

The Endocrine Society recommends against routine population screening. Age is relevant context; it is not a prescription criterion.

Question 4

What is causing the low result?

That question is more important than many men expect.

Low testosterone can reflect a problem at the testes, reduced signaling from the pituitary or hypothalamus, or potentially reversible factors such as acute illness, substantial excess body fat, untreated sleep apnea, opioid use, heavy alcohol use, undernutrition, or previous anabolic-steroid use.

LH and FSH can help distinguish primary from secondary hypogonadism. Other testing may be appropriate when the history suggests pituitary disease, medication effects, thyroid dysfunction, elevated prolactin, or another cause.

Question 5

Will TRT fix my energy, mood, and sex drive?

In appropriately diagnosed men, testosterone therapy may improve sexual desire and activity, anemia related to testosterone deficiency, bone density, lean mass, and selected quality-of-life symptoms. Individual responses vary.

Testosterone is not a treatment for every form of fatigue, low mood, erectile dysfunction, or reduced athletic performance. Inadequate sleep, untreated apnea, alcohol use, depression, cardiovascular disease, medication effects, and relationship factors can contribute to the same symptoms.

The evidence is stronger for certain sexual symptoms in hypogonadal men than it is for broad “anti-aging,” cognitive, or performance promises. If someone guarantees that TRT will make every man feel 25 again, that is marketing—not responsible medicine.

Question 6

Is TRT safe? What about my heart and prostate?

TRT can be appropriate and well tolerated in carefully selected patients with ongoing monitoring. It is not risk-free.

Testosterone can raise hematocrit, and a significant elevation requires clinical evaluation and may require a dose, schedule, or formulation change—or a pause in treatment. I also review blood pressure, cardiovascular and clotting history, sleep apnea, prostate history, urinary symptoms, and PSA when appropriate.

The TRAVERSE trial found testosterone gel was noninferior to placebo for its primary major cardiovascular endpoint in a specific population of middle-aged and older men with confirmed hypogonadism and existing or elevated cardiovascular risk. That finding should not be converted into a claim that testosterone prevents heart disease or is appropriate for every patient.

In 2025, the FDA removed class-wide boxed-warning language about increased cardiovascular outcomes after reviewing TRAVERSE, while requiring broader warnings about increased blood pressure. Product-specific labeling and individual risk assessment still matter.

Question 7

Will TRT affect fertility or shrink my testicles?

Exogenous testosterone can suppress LH and FSH, reduce intratesticular testosterone, decrease sperm production, and reduce testicular volume. If a man is actively trying to conceive, standard TRT is generally not the appropriate first treatment.

Depending on the diagnosis and timing of fertility goals, a physician may discuss addressing reversible causes, sperm banking, avoiding or pausing testosterone, specialist evaluation, or medications intended to stimulate or replace parts of the reproductive-hormone signal.

FDA-approved injectable hCG products include selected cases of hypogonadotropic hypogonadism in males. Using hCG alongside TRT to support testicular function or fertility goals may be off-label depending on the indication and protocol. Enclomiphene is not FDA-approved as a standalone medication in the United States. Neither medication can guarantee sperm preservation, conception, or live birth.

TRT is not reliable contraception, and suppressed sperm production is not always permanent sterility. Recovery after stopping testosterone varies and may take months or longer.

Read the TRT and male fertility cornerstone →
Learn about physician-directed hCG therapy →

Question 8

How is testosterone given, and which method is best?

There is no single delivery method that is best for every patient.

NovaGenix does not offer testosterone pellets. Treatment selection is based on diagnosis, laboratory response, household considerations, cost, preferences, adherence, and medication-specific risks—not one fixed protocol for every man.

Review the NovaGenix physician-led TRT guide →

Question 9

How soon will I notice a change—and what does follow-up involve?

Response varies by symptom, formulation, dose, underlying cause, and the individual patient. Sexual symptoms may change during the first weeks or months, while body-composition and bone effects generally require longer observation. No responsible clinic should promise an identical timeline or outcome for everyone.

If symptoms do not improve despite appropriate levels and adherence, we reassess the diagnosis, dose, delivery method, sleep, medications, mental health, cardiovascular health, and other possible causes rather than escalating indefinitely.

Follow-up is not optional. Monitoring may include testosterone levels, CBC and hematocrit, blood pressure, treatment response, adverse effects, PSA and prostate evaluation when appropriate, and other testing based on the treatment and medical history. Estradiol is evaluated when clinically indicated rather than treated to one universal number.

Question 10

Can I try lifestyle changes first? What if I do not want TRT forever?

Yes. Sometimes lifestyle and treatment of an underlying condition are the correct first steps.

Improving sleep, treating sleep apnea, reducing substantial excess body fat, resistance training, moderating alcohol, improving nutrition, and reviewing contributing medications may improve testosterone or symptoms in selected men.

TRT is not automatically a lifetime commitment, but it should not be treated as a casual short-term experiment. While taking exogenous testosterone, endogenous signaling and production are usually suppressed. If treatment stops, symptoms may return and hormone recovery varies. Changes should be planned with the prescribing clinician rather than made abruptly.

Explore physician-supervised medical weight management →